Incidence, cost, and outcomes of bleeding and chemotherapy dose modificaton among solid tumor patients with chemotherapy-induced thrombocytopenia

Journal of Clinical Oncology

Volumn 19, Issue 4, 2001, Pages 1137-1146

  Elting, L S ^a   Rubenstein, E B ^a   Martin, C G ^a   Kurtin, D ^a   Rodriguez, S ^a   Laiho, E ^a   Kanesan, K ^a   Cantor, S B ^a   Benjamin, R S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; IFOSFAMIDE; LOMUSTINE; MESNA; MITOXANTRONE; PREDNISONE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; COST; DOSE CALCULATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID TUMOR; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0035865439     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.4.1137     Document Type: Article

References (21)

1. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia
2. Incidence of hemorrhagic complications in patients with cancer
3. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors
4. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer
5. Conservative management of chemotherapy-induced thrombocytopenia in women with gynecologic cancers
6. An iconoclastic view of conventional wisdom in hematology
7. Controversies in transfusion medicine: Prophylactic platelet transfusion therapy - Pro
8. Prophylactic platelet transfusion
9. Platelet transfusions: The 20,000/μL trigger
10. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients
11. Concensus conference on platelet transfusion: Royal College of Physicians of Edinburgh
12. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/ml versus 20,000/ml
13. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia
14. Safety and cost effectiveness of a 10 x 109/L trigger for prophylactic platelet transfusions compared with 20 x 109/L trigger: A prospective comparative trial in 105 patients with acute myeloid leukemia
15. A randomized placebocontrolled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy
16. Randomized placebocontrolled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin
17. Clinical use of thrombopoietic growth factors
18. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative trial of nitrogen mustard and trimethylene thiophosphoramide
19. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
20. Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors
21. Pharmacoeconomic analysis ot rhIL-11 for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy